How to Minimize Operational Disruptions in an Outreach Program

In the second quarter of 2026, Mayo Clinic Laboratories expanded its test catalog with several innovative new tests.

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss the Protecting Access to Medicare Act (PAMA) and a recent Cyclospora outbreak making headlines. Later, Dr. Pritt welcomes Juliana Perez Botero, M.D., a Mayo Clinic hematologist, to explore innovative testing approaches for bleeding disorders.

As innovation in clinical diagnostics accelerates, collaboration is becoming increasingly essential to ensure new tools reach the clinicians and patients who need them most. Mary Jo Williamson, chief administrative officer at Mayo Clinic Laboratories, discusses how a strategic approach to collaboration is helping build a more connected diagnostic ecosystem and enabling more comprehensive care.